K-v Pharmaceutical Cl A (KV-A) Cash Flow Statement

Click line-items for a historical chart and %

Net income (loss)	-102.3M
Depreciation and amortization	23.2M
Gain from sale of assets, net
Change in warrant liability
Impairment of intangible assets	31M
Deferred income tax provision	9.9M
Other	1.6M
Receivables, net	23.6M
Inventories	-3.7M
Accounts payable and accrued liabilities	-77.2M
Other assets and liabilities	1.5M
Net cash used in operating activities	-169.3M
Purchase of property and equipment	-100K
Proceeds from sales of property and equipment disposals	0
Proceeds from sale of business/assets, net of fees	53.2M
Proceeds from sale of marketable securities	4.9M
Net cash provided by investing activities	85M
Payments on debt, net
Net cash used in financing activities	-2.4M
Effect of foreign exchange rate changes on cash	-200K
Decrease in cash and cash equivalents	-86.9M
Beginning of period	137.6M
End of period	50.7M
Interest paid	33.8M
Stock options exercised (at expiration of two-year forfeiture period)	100K

Entities mentioned with KV-A

View All Entities